Nuwellis (NUWE) announced that it has entered into a Securities Purchase Agreement to acquire all of the issued and outstanding capital stock of Rendiatech Ltd., an Israeli-based medical technology company focused on automated kidney function monitoring. The transaction is expected to close following the satisfaction of customary closing conditions. The transaction has been approved by the boards of directors of both companies.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Here’s Why Nuwellis Stock (NUWE) Rocketed Today
- Nuwellis refreshes board amid linked capital raise plans
- Nuwellis announces issuance of new U.S. patent on extracorporeal therapy
- Nuwellis announces presentation of data on broad utility of Aquadex